Medtech regulatory affairs is increasingly pressurised, as RA teams face unprecedented volume and complexity of tasks under tight timelines. Generative AI offers huge benefits, but only with sufficient human oversight.
Explore study findings on the impact of AI on medtech regulatory tasks, highlighting:
- The current impact of Gen AI in medtech, including benefits, limitations and challenges
- How six leading language models (LLMs) performed against human experts in RA tasks covering strategic advice, device classification and information retrieval
- Performance to Safety: Key Lessons and the Critical Role of Human Oversight
- Practical guidance for using LLMs as a useful accessory to human expertise in medtech